Brand name · Chemotherapy / PD-L1 Biologic
Imfinzi (Durvalumab) J-Code / HCPCS Code
In short
Imfinzi is billed under HCPCS J9173 — Injection, durvalumab, 10 mg. One billing unit is 10 mg.
Reference
- Code
- J9173 — Injection, durvalumab, 10 mgMed-Code curated
- Billing unit
- 10 mg
- Same code in the directory
- Durvalumab
- Pharmacologic class
- Programmed Death Ligand-1 BlockerFrom the FDA listings below
- Labelers
- AstraZeneca Pharmaceuticals LP
- J-code category
- Chemotherapy / PD-L1 Biologic
FDA-listed products
Finished products whose name and route match this directory entry.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Imfinzidurvalumab | Durvalumab 120 mg/2.4mL | Injection, SolutionIntravenous | AstraZeneca Pharmaceuticals LP | 0310-4500 |
| Imfinzidurvalumab | Durvalumab 500 mg/10mL | Injection, SolutionIntravenous | AstraZeneca Pharmaceuticals LP | 0310-4611 |
NDCs billed under J9173
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 2 NDCs to J9173 for Imfinzi. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Imfinzi | 00310-4500-12 | AstraZeneca Pharmaceuticals LP | 2.4 | 12 |
| Imfinzi | 00310-4611-50 | AstraZeneca Pharmaceuticals LP | 10 | 50 |